101 Flashcards
What are the grades of blunt thoracic aortic trauma
- Intimal injury - medical management
- Mural hematoma
- Pseudoaneurysm
- Contained rupture
What is CREST 2
A trial comparing carotid endarterectomy to best medical management and carotid stenting to best medical management, and asymptomatic patients 
What are 4 exclusión criteria for EVAR
Widely accepted exclusion criteria for EVAR include:
1. proximal neck length less than 10 mm
2. proximal neck diameter greater than 32 mm
3. neck angulation greater than 60 degrees
4. external iliac diameter of less than 6mm
Velocity criteria for severe carotid stenosis
PSV Greater than 230
>50% plaque
Internal:common psv ratio >4
EDV > 100
Velocity criteria for moderate carotid stenosis 50-69%
ICA PSV 180-230
Plaque >50
ICA:CCA PSV Ratio 2-4
ICA EDV 40-100
Rutherford classification for chronic ischemia
Stage 0 - asx
Stage 1 - mild claudication
Stage 2- moderate claudication
Stage 3 - severe claudication
Stage 4 - rest pain
Stage 5 - minor tissue loss
Stage 6 - major tissue loss
Rutherford classification for acute limb ischemia
I. Intact sensory motor, Doppler signals present, cap refill intact
IIa. Loss of arterial Doppler signals. Mild sensory changes. Motor intact. Cap refill delayed. Urgent OR
IIb. Motor deficits. Worsening sensory deficits. Immediate OR
III. Paralysis and complete sensory loss. Loss of venous Doppler signals. No cap refill. Unsalvageable
Wifi classification
Reflux time for superficial and deep veins to be considered significant
Superficial greater than 0.5, deep greater than 1 second
Exclusion for TCAR
- Distance between access site (common carotid above the clavicle) and lesion less than 5cm
- Diameter of CCA less than 6mm
- Access and occlusion sites with significant disease
- Visible Thrombus
- Circumferential plaque/calcification
- Tortuosity, small diameter ICA
Relative: neck radiation, tracheostomy
Best-CLI Trial
Prospective open label trial comparing two cohorts, NEJM December 2022
Cohort 1 was patients with suitable single segment of greater saphenous vein- in this group surgery was superior to endo (major adverse limb events/death)
Cohort 2 was patients without suitable single segment saphenous. In this group surgery and endo we’re equivalent
Adequate gsv diameter for bypass
3mm; 2-3 marginal
Timing of CEA after stroke
48hrs - 14 days
Popliteal artery aneurysm size threshold for repair
Biochemical work up for carotid body tumor
Screen with serum metanephrines and serum dopamine if positive follow up with 24 hr urine metanephrines
(See email with Wachtel)
Describe the Voyager trial
RCT of Compass dose xarelto (2.5 bid) and Asa compared to Asa alone in PAD patients with revascularization with regards to composite outcome of ALI, major amputation, MI, stroke or death from CV causes. TIMI bleeding not significantly higher but ISHT major bleeding was
Describe the compass trial
In patients with stable atherosclerotic disease, three groups: asa 100mg, full strength rivaroxaban (xarelto), or low dose rovaroxaban (2.5 bid) AND asa 100mg were compared with respect to a composite outcome of cardiovascular death, MI or stroke. Combo low dose xarelto and asa had lower rates of primary outcome, higher rates of major bleeding than Asa alone. Xarelto alone had similar rates of primary outcome but higher rates of bleeding to Asa alone
CREST Trial
EMINENT Trial
ZILVER PTX Trial
BATTLE Trial
IMPERIAL Trial
BASIL Trial
NASCET